The levels of immune reactivity of peripheral and blood T-lymphocytes were evaluated in 37 bladder cancer patients and 31 age-matched controls. T-lymphocyte subsets were quantified by monoclonal antibodies, and the immune reactivity was measured using stimulation with phytohemagglutinin (PHA), conca
Distribution of T-cell subpopulations in the peripheral blood of patients with erythrodermic psoriasis
β Scribed by R. Willemze; W. J. M. Damsteeg; C. J. L. M. Meijer
- Publisher
- Springer-Verlag
- Year
- 1984
- Tongue
- English
- Weight
- 453 KB
- Volume
- 277
- Category
- Article
- ISSN
- 0340-3696
No coin nor oath required. For personal study only.
β¦ Synopsis
In the present study the percentages of T cells and T-cell subsets, as defined by Fc receptors and monoclonal antibodies (OKT3, OKT4, OKT8, HLA-DR) were determined in the peripheral blood of 12 patients with psoriasis, including six patients with erythroderma and 6 with active, but limited disease. The patients with erythroderma were studied before treatment and 4-8 weeks following. The mean percentages of E-rosette-forming cells and T-cell subsets reactive with the monoclonal antibodies OKT3, OKT4 and OKT8 were within normal limits, as were the percentages of T mu-cells, irrespective of the extent or activity of the disease. The mean percentage of T gamma-cells was reduced in the patients with untreated erythrodermic psoriasis but not in the patients with limited disease. Comparison of the T gamma values in the erythroderma group before and after therapy showed a slight, but statistically significant increase (P less than 0.03). These results indicate a direct relationship between the T gamma deficit and the extent of skin involvement, and argue against a primary suppressor T-cell defect in psoriasis vulgaris.
π SIMILAR VOLUMES
## Abstract Peripheral blood lymphocytes from 13 children with newly diagnosed untreated nonβHodgkin malignant lymphoma were investigated for the proportion of TΞΌ and TΞ³ cells. Tumor involvement was classified as stage II in two patients, stage III in five patients, and stage IV in six patients. Di